Technical Note—On the Quasiconcavity of Lost-Sales Inventory Models with Fixed CostsQING LI; PEIWEN YU.Operations research. 2012, Vol 60, Num 2, pp 286-291, issn 0030-364X, 6 p.Article

p15^PAF, a novel PCNA associated factor with increased expression in tumor tissuesPEIWEN YU; HUANG, Betty; SHEN, Mary et al.Oncogene (Basingstoke). 2001, Vol 20, Num 4, pp 484-489, issn 0950-9232Article

The Novel Bacterial N-Demethylase PdmAB Is Responsible for the Initial Step of N,N-Dimethyl-Substituted Phenylurea Herbicide DegradationTAO GU; CHAOYANG ZHOU; SØRENSEN, Sebastian R et al.Applied and environmental microbiology (Print). 2013, Vol 79, Num 24, pp 7846-7856, issn 0099-2240, 11 p.Article

Discovery of XL413, a potent and selective CDC7 inhibitorKOLTUN, Elena S; LEW TSUHAKO, Amy; GALAN, Adam et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 11, pp 3727-3731, issn 0960-894X, 5 p.Article

The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitorsKIM, Moon H; LEW TSUHAKO, Amy; LE, Donna T et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 15, pp 4979-4985, issn 0960-894X, 7 p.Article

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine KinasesFAWN QIAN; ENGST, Stefan; LOUGHEED, Julie et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 20, pp 8009-8016, issn 0008-5472, 8 p.Article

The design, synthesis, and biological evaluation of PIM kinase inhibitorsAMY LEW TSUHAKO; BROWN, David S; PING HUANG et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 11, pp 3732-3738, issn 0960-894X, 7 p.Article

SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitorsFORSYTH, Timothy; KEARNEY, Patrick C; EPSHTEYN, Sergey et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7653-7658, issn 0960-894X, 6 p.Article

Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic-Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK InhibitorWONG, Harvey; VERNILLET, Laurent; HOEFLICH, Klaus P et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3090-3099, issn 1078-0432, 10 p.Article

Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647GENDREAU, Steven B; VENTURA, Richard; JACKMAN, Lisa et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3713-3723, issn 1078-0432, 11 p.Article